CVS Health Enters Biosimilars Market with Launch of Cordavis Subsidiary

Consumer healthcare brand CVS Health on Wednesday launched Cordavis, a wholly owned subsidiary focused on the growing U.S. biosimilars market that will work directly with manufacturers.